INFLAMMATION of salivary tissue (SALIVARY GLANDS), usually due to INFECTION or injuries.
"Salivary gland diseases refer to a group of medical conditions that affect the function, structure, or health of the salivary glands, leading to symptoms such as dry mouth, swelling, pain, and abnormal secretions."
Submandibular Gland Diseases refer to a group of medical conditions affecting the structure and function of the submandibular glands, leading to symptoms such as swelling, pain, difficulty swallowing, and reduced saliva production.
Submandibular Gland Neoplasms are abnormal growths or tumors, which can be benign or malignant, originating from the glandular tissues of the submandibular salivary gland located beneath the mandible (jawbone).
Calculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotid gland and in the sublingual and minor salivary glands.
Presence of small calculi in the terminal salivary ducts (salivary sand), or stones (larger calculi) found in the larger ducts.
Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).
One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)
Inflammation of the lacrimal sac. (Dorland, 27th ed)
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
Radiography of the SALIVARY GLANDS or ducts following injection of contrast medium.
A rare aberrant human behavior involving consumption of excrement.
A mouse substrain that is genetically predisposed to the development of systemic lupus erythematosus-like syndrome, which has been found to be clinically similar to the human disease. It has been determined that this mouse strain carries a mutation in the fas gene. Also, the MRL/lpr is a useful model to study behavioral and cognitive deficits found in autoimmune diseases and the efficacy of immunosuppressive agents.
INFLAMMATION of the PAROTID GLAND.
Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.
A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.
Tumors or cancer of the SALIVARY GLANDS.

Effect of the synthetic immunomodulator, linomide, on experimental models of thyroiditis. (1/137)

The drug Linomide is an immunomodulator showing marked down-regulation of several experimental autoimmune diseases. In this study, its effect on three different experimental models of thyroid disease and on spontaneous infiltration of salivary glands (sialoadenitis), was investigated. Although very effective at preventing thyroid infiltrates in mice immunized with mouse thyroglobulin and complete Freund's adjuvant and in spontaneous models of thyroiditis and sialoadenitis, it completely failed to modify experimental autoimmune thyroiditis (EAT) induced in mice immunized with mouse thyroglobulin and lipopolysaccharide. There was no significant shift in the observed isotypes of anti-mouse thyroglobulin antibodies and only anti-mouse thyroglobulin antibodies in the spontaneous model were completely down-modulated by the drug. One surprising fact to emerge was that Linomide-treated donor mice, although protected from thyroid lesions themselves, were still able to transfer EAT showing that they must have been effectively primed while being treated with Linomide. It is possible that the drug down modulated EAT by interfering with the trafficking of primed effector cells.  (+info)

A case of coprophagia presenting with sialadenitis. (2/137)

PRESENTATION: a 94-year-old woman with dementia was admitted to an acute geriatric ward with increasing confusion and falls. On two occasions she developed submandibular masses. Faeces were aspirated from her mouth and a diagnosis made of recurrent submandibular sialadenitis secondary to coprophagia. OUTCOME: the submandibular mass settled with antibiotics and oral care. Coprophagia was not observed on the ward, but faecal smearing was noted. With regular toileting, this behaviour ceased and sialadenitis did not recur.  (+info)

The MR imaging assessment of submandibular gland sialoadenitis secondary to sialolithiasis: correlation with CT and histopathologic findings. (3/137)

BACKGROUND AND PURPOSE: MR imaging has been proved to be effective in depicting wide variety of pathologic changes of the salivary gland. Therefore, we evaluated clinical usefulness of MR imaging for sialolithiasis. METHODS: Sixteen patients with sialolithiasis of the submandibular gland underwent MR imaging. MR images of the glands were obtained with a conventional (T1-weighted), fast spin-echo (fat-suppressed T2-weighted) and short inversion time-inversion recovery sequences. Contrast enhancement was not used. MR imaging features then were compared with clinical symptoms, histopathologic features of excised glands, and CT imaging features. RESULTS: Submandibular glands with sialolithiasis could be classified into three types on the basis of clinical symptoms and MR imaging features of the glands. Type I glands were positive for clinical symptoms and MR imaging abnormalities, and were characterised histopathologically by active inflammation (9 [56%] of 16). Type II glands were negative for clinical symptoms and positive for MR imaging abnormalities (4 [25%] of 16), and the glands were replaced by fat. Type III glands were negative for clinical symptoms and MR imaging abnormalities (3 [19%] of 16). CT features of these glands correlated well with those of MR imaging. CONCLUSION: These results suggest that MR imaging features may reflect chronic and acute obstruction, and a combination of CT and MR imaging may complement each other in examining glands with sialolithiasis.  (+info)

Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. (4/137)

OBJECTIVE: To clarify the mode of inheritance of autoimmune sialadenitis in MRL/MpJ-lpr/lpr (MRL/lpr) lupus-prone mice and identify the susceptibility loci. METHODS: MRL/lpr, C3H/HeJ-lpr/lpr (C3H/lpr), (MRL/lpr x C3H/lpr)F1 intercross, and MRL/lpr x (MRL/lpr x C3H/lpr)F1 backcross mice were prepared, and sialadenitis in individual mice was analyzed by histopathologic grading. The genomic DNA of the backcross mice was examined by simple sequence-length polymorphism analysis, and the highly associated polymorphic microsatellite markers with sialadenitis were determined as sialadenitis susceptibility loci. RESULTS: Four susceptible gene loci recessively associated with sialadenitis were mapped on chromosomes 10, 18, 4, and 1, respectively. These loci manifested additive and hierarchical properties in the development of sialadenitis. CONCLUSION: The results indicate that sialadenitis in MRL/lpr mice is under the control of polygenic inheritance, possibly involving allelic polymorphism.  (+info)

In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. (5/137)

Although DQA1*0301/DQB1*0302 is the human histocompatibility leukocyte antigen (HLA) class II gene most commonly associated with human type 1 diabetes, direct in vivo experimental evidence for its diabetogenic role is lacking. Therefore, we generated C57BL/6 transgenic mice that bear this molecule and do not express mouse major histocompatibility complex (MHC) class II molecules (DQ8(+)/mII(-)). They did not develop insulitis or spontaneous diabetes. However, when DQ8(+)/mII(-) mice were bred with C57BL/6 mice expressing costimulatory molecule B7-1 on beta cells (which normally do not develop diabetes), 81% of the DQ8(+)/mII(-)/B7-1(+) mice developed spontaneous diabetes. The diabetes was accompanied by severe insulitis composed of both T cells (CD4(+) and CD8(+)) and B cells. T cells from the diabetic mice secreted large amounts of interferon gamma, but not interleukin 4, in response to DQ8(+) islets and the putative islet autoantigens, insulin and glutamic acid decarboxylase (GAD). Diabetes could also be adoptively transferred to irradiated nondiabetic DQ8(+)/mII(-)/B7-1(+) mice. In striking contrast, none of the transgenic mice in which the diabetes protective allele (DQA1*0103/DQB1*0601, DQ6 for short) was substituted for mouse MHC class II molecules but remained for the expression of B7-1 on pancreatic beta cells (DQ6(+)/mII(-)/B7-1(+)) developed diabetes. Only 7% of DQ(-)/mII(-)/B7-1(+) mice developed diabetes at an older age, and none of the DQ(-)/mII(+)/B7-1(+) mice or DQ8(+)/mII(+)/B7-1(+) mice developed diabetes. In conclusion, substitution of HLA-DQA1*0301/DQB1*0302, but not HLA-DQA1*0103/DQB1*0601, for murine MHC class II provokes autoimmune diabetes in non-diabetes-prone rat insulin promoter (RIP).B7-1 C57BL/6 mice. Our data provide direct in vivo evidence for the diabetogenic effect of this human MHC class II molecule and a unique "humanized" animal model of spontaneous diabetes.  (+info)

Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjogren's syndrome? (6/137)

OBJECTIVES: Prospectively collected computer database information was previously assessed on a cohort of 300 patients who fulfilled the Copenhagen classification criteria for primary Sjogren's syndrome. Analysis of the clinical data showed that patients who smoked had a decreased lower lip salivary gland focus score (p<0.05). The aim of this original report is to describe the tobacco habits in patients with primary Sjogren's syndrome or stomatitis sicca only and to determine if there is a correlation between smoking habits and focus score in lower lip biopsies as well as ciculating autoantibodies and IgG. METHODS: All living patients with primary Sjogren's syndrome or stomatitis sicca only, who were still in contact with the Sjogren's Syndrome Research Centre were asked to fill in a detailed questionnaire concerning present and past smoking habits, which was compared with smoking habits in a sex and age matched control group (n=3700) from the general population. In addition, the patients previous lower lip biopsies were blindly re-evaluated and divided by the presence of focus score (focus score = number of lymphocyte foci per 4 mm(2) glandular tissue) into those being normal (focus score 1). Furthermore the cohort was divided into three groups; 10-45, 46-60 and >/= 61 years of age. Finally the focus score was related to the smoking habits. Seroimmunological (ANA; anti-SSA/Ro antibodies; anti-SSB/La antibodies; IgM-RF and IgG) samples were analysed routinely. RESULTS: The questionnaire was answered by 98% (n=355) of the cohort and the percentage of current smokers, former smokers and historical non-smokers at the time of lower lip biopsy was not statistically different from that of the control group. Cigarette smoking at the time of lower lip biopsy is associated with lower risk of abnormal focus score (p<0.001; odds ratio 0.29, 95%CI 0.16 to 0.50). The odds ratio for having focal sialadenitis (focus score > 1) compared with having a non-focal sialadenitis or normal biopsy (focus score /= 61: odds ratio 0.36, 95%CI 0.10 to 1.43) although there was only statistical significance in the two younger age groups. Moreover, among current smokers at the time of the lower lip biopsy there was a decreasing odds ratio for an abnormal lip focus score with increasing number of cigarettes smoked per week (p trend 0.00). In the group of former smokers, which included patients that had stopped smoking up to 30 years ago, the results were in between those of the smokers and the historical non-smokers (odds ratio 0.57, 95%CI 0.34 to 0.97, compared with never smokers). Present or past smoking did not correlate with the function of the salivary glands as judged by unstimulated whole sialometry, stimulated whole sialometry or salivary gland scintigraphy. Among former smokers, the median time lapse between the first symptom of primary Sjogren's syndrome and the performance of the lower lip biopsy was approximately half as long as the median time lapse between smoking cessation and biopsy (8 versus 15 years). Hence, symptoms of Sjogren's syndrome are unlikely to have had a significant influence on smoking habits at the time of the biopsy. Among the seroimmunological results only anti-SSA/Ro and anti-SSB/La antibodies reached statistical significance in a manner similar to the way smoking influenced the focus score in lower lip biopsies. On the other hand the level of significance was consistently more pronounced for the influence of smoking on the focus score than for the influence on anti-SSA/Ro and anti-SSB/La autoantibodies. CONCLUSION: This is believed to be the first report showing that cigarette smoking is negatively associated with focal sialadenitis-focus score >1-in lower lip biopsy in patients with primary Sjogren's syndrome. Furthermore, tobacco seems to decrea  (+info)

Primary structure of the sialodacryoadenitis virus genome: sequence of the structural-protein region and its application for differential diagnosis. (7/137)

Sialodacryoadenitis virus (SDAV) is a coronavirus that is commonly found in laboratory rats and that causes sialodacryoadenitis and respiratory illness. We cloned and sequenced the 3' terminal 9.8 kb of the genomic RNA and analyzed the structure of the viral genome. As with mouse hepatitis coronaviruses (MHVs), the SDAV genome was able to code for a spike protein, a small membrane protein, a membrane-associated protein, and a nucleocapsid protein. In addition, the hemagglutinin-esterase gene capable of encoding a protein of 439 amino acids (aa) was identified. The putative functional site for acetylesterase activity was present in the HE protein as Phe-Gly-Asp-Ser (FGDS), suggesting that the SDAV HE protein might have retained the esterase activity. Immediately upstream of the HE gene and downstream of the polymerase 1b gene, the NS2 nonstructural-protein gene was identified with a coding capacity of 274 aa. A motif of UCUAAAC was identified as a potential transcription signal for subgenomic mRNA synthesis. Large insertions of 172, 127, and 44 aa were detected in the N-terminal half of the predicted S protein of SDAV when its sequence was compared to the sequences of MHV 2, MHV JHM, and MHV A59, respectively. The sequence information on the SDAV S-protein gene was applied to a differential diagnostic PCR to detect and distinguish the rat coronavirus from mouse coronaviruses. This is the first report on the comprehensive genetic information of any rat coronavirus.  (+info)

"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren's syndrome patients: possible participation in lymphoid structure formation. (8/137)

OBJECTIVE: Many studies have shown that the microanatomic organization of infiltrating leukocytes in the salivary gland lesions of patients with Sjogren's syndrome (SS) resembles the structure of lymphoid organs. A newly defined set of chemokines referred to as "lymphoid," which orchestrate leukocyte microenvironmental homing and contribute to the formation of lymphoid structures, provides directional clues. The aim of this study was to investigate the possible existence of "lymphoid" chemokines in the chronic inflammatory lesions of SS patients and thus validate their potential involvement in the disease process. METHODS: Twelve patients with primary SS, 3 patients with secondary SS, 4 patients with other autoimmune disorders, and 4 control individuals were the subjects of this study. Reverse transcriptase-polymerase chain reaction analysis was performed in order to examine the messenger RNA (mRNA) expression of "lymphoid" chemokines. Furthermore, in situ hybridization studies revealed chemokine mRNA localization. Immunohistochemistry was also applied in order to identify the cell types that expressed the chemokine mRNA. RESULTS: STCP-1/monocyte-derived chemokine and TARC mRNA were expressed in the majority of patients with primary and secondary SS, in 2 of 4 patients with other autoimmune disorders, and in 2 of 4 controls. BCA-1, ELC, and PARC mRNA were only detected in patients with primary and secondary SS. SLC mRNA was also detected in 1 non-SS patient. The main cellular sources of chemokine mRNA were ductal epithelial cells and infiltrating mononuclear leukocytes. CONCLUSION: The expression pattern of "lymphoid" chemokine mRNA points further to the role of epithelial cells in the pathogenesis of SS and offers new insight into the potential mechanisms that could be involved in leukocyte attraction and in the in situ formation of secondary lymphoid tissue structures.  (+info)

Sialadenitis is a medical condition characterized by inflammation of the salivary gland. It can occur in any of the major salivary glands, including the parotid, submandibular, and sublingual glands. The inflammation may result from bacterial or viral infections, autoimmune disorders, or obstruction of the salivary ducts.

Acute sialadenitis is often caused by bacterial infections and can lead to symptoms such as pain, swelling, redness, and difficulty swallowing. Chronic sialadenitis, on the other hand, may be caused by recurrent infections, autoimmune disorders like Sjogren's syndrome, or stones in the salivary ducts. Symptoms of chronic sialadenitis can include intermittent swelling, pain, and dry mouth.

Treatment for sialadenitis depends on the underlying cause but may include antibiotics, anti-inflammatory medications, hydration, and massage of the salivary glands. In some cases, surgery may be necessary to remove obstructions or damaged tissue in the salivary gland.

Salivary gland diseases refer to a group of conditions that affect the function and structure of the salivary glands. These glands are responsible for producing saliva, which helps in digestion, lubrication, and protection of the mouth and throat. The major salivary glands include the parotid, submandibular, and sublingual glands.

There are several types of salivary gland diseases, including:

1. Salivary Gland Infections: These are usually caused by bacteria or viruses that infect the gland, ducts, or surrounding tissues. The most common infection is called sialadenitis, which can cause pain, swelling, redness, and difficulty swallowing.

2. Salivary Gland Stones (Sialolithiasis): These are small, hard deposits that form in the ducts of the salivary glands, causing blockages and leading to swelling, pain, and infection.

3. Salivary Gland Tumors: Both benign and malignant tumors can develop in the salivary glands. Benign tumors are usually slow-growing and cause localized swelling, while malignant tumors may be more aggressive and spread to other parts of the body.

4. Salivary Gland Dysfunction: This refers to conditions that affect the production or flow of saliva, such as Sjogren's syndrome, radiation therapy, dehydration, or certain medications.

5. Autoimmune Disorders: Conditions like Sjogren's syndrome, lupus, and rheumatoid arthritis can affect the salivary glands and cause inflammation, dry mouth, and other symptoms.

6. Salivary Gland Trauma: Injuries to the face or neck can damage the salivary glands and lead to swelling, bleeding, or decreased function.

Proper diagnosis and treatment of salivary gland diseases require a thorough evaluation by a healthcare professional, often involving imaging studies, laboratory tests, and biopsies. Treatment options may include antibiotics, surgery, radiation therapy, or changes in medication or lifestyle.

Submandibular gland diseases refer to a group of disorders that affect the function or structure of the submandibular glands, which are salivary glands located beneath the jaw and produce saliva. These diseases can be categorized into inflammatory, infectious, obstructive, neoplastic (benign or malignant), and autoimmune disorders.

Some common submandibular gland diseases include:

1. Submandibular sialadenitis: Inflammation of the submandibular gland due to bacterial or viral infections, stones, or autoimmune conditions.
2. Salivary gland stones (sialolithiasis): Calcified deposits that obstruct the ducts leading from the submandibular gland, causing swelling and pain, especially during meals.
3. Submandibular gland tumors: Abnormal growths in the submandibular gland, which can be benign or malignant (cancerous). Malignant tumors may invade surrounding tissues and spread to other parts of the body.
4. Sjögren's syndrome: An autoimmune disorder that affects the exocrine glands, including the submandibular gland, leading to dry mouth and eyes.
5. IgG4-related disease: A systemic inflammatory condition characterized by the infiltration of IgG4-positive plasma cells into various organs, including the submandibular gland, causing swelling and damage.
6. Mikulicz's disease: A rare benign lymphoepithelial lesion that affects the salivary and lacrimal glands, including the submandibular gland, leading to enlargement and dryness of the affected glands.
7. Salivary gland dysfunction: Reduced or impaired saliva production due to aging, medications, radiation therapy, or systemic diseases, which can affect the submandibular gland.

Proper diagnosis and treatment of submandibular gland diseases require a thorough clinical evaluation, imaging studies, and sometimes biopsy or surgical intervention.

Submandibular gland neoplasms refer to abnormal growths or tumors that develop in the submandibular glands. These are one of the three pairs of major salivary glands located beneath the jaw and produce saliva that helps in digestion. Submandibular gland neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign neoplasms are typically slow-growing, do not invade surrounding tissues, and rarely spread to other parts of the body. Common types of benign submandibular gland neoplasms include pleomorphic adenomas and monomorphic adenomas.

Malignant neoplasms, on the other hand, are aggressive and can invade nearby structures or metastasize (spread) to distant organs. Common types of malignant submandibular gland neoplasms include mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma.

Symptoms of submandibular gland neoplasms may include a painless swelling or mass in the neck, difficulty swallowing, speaking, or breathing, numbness or tingling in the tongue or lips, and unexplained weight loss. Treatment options depend on the type, size, location, and stage of the tumor but often involve surgical excision, radiation therapy, and/or chemotherapy. Regular follow-up care is essential to monitor for recurrence or metastasis.

Salivary gland calculi, also known as salivary duct stones or sialoliths, are small, hard deposits that form in the salivary glands or their ducts. These calculi typically consist of calcium salts and other minerals, and can vary in size from a few millimeters to over a centimeter in diameter.

Salivary gland calculi can cause a range of symptoms, including pain, swelling, and difficulty swallowing, particularly during meals. The obstruction of the salivary duct by the calculus can lead to infection or inflammation of the salivary gland (sialadenitis).

The most common location for salivary gland calculi is in the submandibular gland and its duct, followed by the parotid gland and then the sublingual gland. Treatment options for salivary gland calculi include conservative management with hydration, massage, and warm compresses, as well as more invasive procedures such as extracorporeal shock wave lithotripsy, sialendoscopy, or surgical removal of the calculus.

Salivary duct calculi, also known as salivary gland stones or salivary duct stones, are small, hard deposits that form in the salivary glands or their ducts. These stones typically consist of calcium salts and other minerals, and they can range in size from tiny grains to larger pebbles.

Salivary duct calculi can cause a variety of symptoms, including pain, swelling, and difficulty swallowing. They may also lead to infection or inflammation of the salivary glands. In severe cases, surgery may be necessary to remove the stones and relieve the associated symptoms.

The formation of salivary duct calculi is thought to be related to a variety of factors, including dehydration, decreased saliva production, and changes in the composition of saliva. People who have certain medical conditions, such as gout or hyperparathyroidism, may also be at increased risk for developing these stones.

Salivary glands are exocrine glands that produce saliva, which is secreted into the oral cavity to keep the mouth and throat moist, aid in digestion by initiating food breakdown, and help maintain dental health. There are three major pairs of salivary glands: the parotid glands located in the cheeks, the submandibular glands found beneath the jaw, and the sublingual glands situated under the tongue. Additionally, there are numerous minor salivary glands distributed throughout the oral cavity lining. These glands release their secretions through a system of ducts into the mouth.

The submandibular glands are one of the major salivary glands in the human body. They are located beneath the mandible (jawbone) and produce saliva that helps in digestion, lubrication, and protection of the oral cavity. The saliva produced by the submandibular glands contains enzymes like amylase and mucin, which aid in the digestion of carbohydrates and provide moisture to the mouth and throat. Any medical condition or disease that affects the submandibular gland may impact its function and could lead to problems such as dry mouth (xerostomia), swelling, pain, or infection.

Dacryocystitis is a medical condition that refers to the inflammation of the lacrimal sac, which is a small sac-like structure located in the inner corner of the eye near the nose. The lacrimal sac is responsible for draining tears from the eye into the nasal cavity.

Dacryocystitis can occur as a result of an infection or obstruction in the tear drainage system, leading to the accumulation of tears and other debris in the lacrimal sac. This can cause symptoms such as redness, swelling, pain, and tenderness in the affected area, as well as discharge from the eye or nose.

In some cases, dacryocystitis may be treated with antibiotics to clear up any infection. In more severe cases, surgery may be required to remove any blockages and improve tear drainage. If left untreated, dacryocystitis can lead to complications such as the formation of an abscess or damage to the eye.

Sjögren's syndrome is a chronic autoimmune disorder in which the body's immune system mistakenly attacks its own moisture-producing glands, particularly the tear and salivary glands. This can lead to symptoms such as dry eyes, dry mouth, and dryness in other areas of the body. In some cases, it may also affect other organs, leading to a variety of complications.

There are two types of Sjögren's syndrome: primary and secondary. Primary Sjögren's syndrome occurs when the condition develops on its own, while secondary Sjögren's syndrome occurs when it develops in conjunction with another autoimmune disease, such as rheumatoid arthritis or lupus.

The exact cause of Sjögren's syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment typically focuses on relieving symptoms and may include artificial tears, saliva substitutes, medications to stimulate saliva production, and immunosuppressive drugs in more severe cases.

Sialography is a medical imaging technique used to examine the ducts (salivary glands) that carry saliva from the salivary glands to the mouth. In this procedure, a radiopaque contrast material is injected into the salivary gland, and then X-rays or other forms of imaging are taken to visualize the shape and any abnormalities in the ducts.

The contrast material outlines the ducts on the images, allowing healthcare professionals to identify any blockages, narrowing, dilations, stones, or other abnormalities that may be present in the salivary glands. Sialography is typically used to diagnose and manage conditions such as salivary gland inflammation, obstruction, or infection.

It's worth noting that sialography has been largely replaced by newer imaging techniques, such as ultrasound, CT scans, and MRI, which do not require the injection of a contrast material and are generally considered safer and more comfortable for patients. However, sialography may still be used in certain cases where these other methods are not sufficient to make an accurate diagnosis.

Coprophagia is a term that refers to the consumption of feces. When this behavior is observed in humans, it is considered atypical and is often associated with certain mental health disorders or side effects of medication.

It's important to note that coprophagia in humans can also be indicative of underlying medical conditions such as malabsorption syndromes, where the individual may not be getting enough nutrients from their food and could be seeking them through this unusual means. However, such cases are rare.

This behavior is generally considered unhealthy and unsanitary due to the risk of infection from various pathogens that can be present in feces. If you or someone else is experiencing this, it's recommended to seek help from a healthcare professional to address the root cause.

'Mice, Inbred MRL-lpr' refers to a specific strain of laboratory mice that are used in biomedical research. The 'MRL' part of the name stands for the breeding colony where they were originally developed, which is the Mouse Repository at the Jackson Laboratory in Bar Harbor, Maine. The 'lpr' designation indicates that these mice carry a mutation in the Fas gene, also known as lpr (lymphoproliferation) gene, which leads to an autoimmune disorder characterized by lymphadenopathy (enlarged lymph nodes), splenomegaly (enlarged spleen), and production of autoantibodies.

The MRL-lpr mice are known for their accelerated aging phenotype, which includes the development of a variety of age-related diseases such as atherosclerosis, osteoporosis, and cancer. They also develop a severe form of systemic lupus erythematosus (SLE), an autoimmune disease that affects many organs in the body. The MRL-lpr mice are widely used as a model to study the pathogenesis of SLE and other autoimmune diseases, as well as to test potential therapies for these conditions.

It is important to note that while inbred mouse strains like MRL-lpr provide valuable insights into human disease mechanisms, they do not perfectly replicate all aspects of human disease, and results obtained in mice may not always translate directly to humans. Therefore, findings from mouse studies should be interpreted with caution and validated in human studies before being applied in clinical practice.

Parotitis is the medical term for inflammation of the parotid gland, which is one of the major salivary glands located in the face, near the ear. The condition can result from various causes, including bacterial or viral infections, autoimmune disorders, or obstruction of the salivary ducts.

Parotitis can cause symptoms such as pain, swelling, redness, and difficulty swallowing. In some cases, it may also lead to fever, chills, and general malaise. The diagnosis of parotitis typically involves a physical examination, medical history, and sometimes imaging studies or laboratory tests to identify the underlying cause. Treatment depends on the specific cause but may include antibiotics, pain relievers, hydration, and measures to improve salivary flow.

Minor salivary glands are numerous small exocrine glands that produce saliva and are distributed throughout the oral cavity, nasal cavity, pharynx, larynx, and paranasal sinuses. They are classified as "minor" due to their smaller size compared to the three pairs of major salivary glands (parotid, submandibular, and sublingual). The minor salivary glands are primarily mucous glands, although some contain serous cells. They are responsible for producing approximately 5-10% of the total saliva in the mouth. These glands help moisten the oral cavity, protect the mucosal lining, and facilitate speaking, chewing, and swallowing.

Autoimmune diseases are a group of disorders in which the immune system, which normally protects the body from foreign invaders like bacteria and viruses, mistakenly attacks the body's own cells and tissues. This results in inflammation and damage to various organs and tissues in the body.

In autoimmune diseases, the body produces autoantibodies that target its own proteins or cell receptors, leading to their destruction or malfunction. The exact cause of autoimmune diseases is not fully understood, but it is believed that a combination of genetic and environmental factors contribute to their development.

There are over 80 different types of autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, psoriasis, and inflammatory bowel disease. Symptoms can vary widely depending on the specific autoimmune disease and the organs or tissues affected. Treatment typically involves managing symptoms and suppressing the immune system to prevent further damage.

The parotid gland is the largest of the major salivary glands. It is a bilobed, accessory digestive organ that secretes serous saliva into the mouth via the parotid duct (Stensen's duct), located near the upper second molar tooth. The parotid gland is primarily responsible for moistening and lubricating food to aid in swallowing and digestion.

Anatomically, the parotid gland is located in the preauricular region, extending from the zygomatic arch superiorly to the angle of the mandible inferiorly, and from the masseter muscle anteriorly to the sternocleidomastoid muscle posteriorly. It is enclosed within a fascial capsule and has a rich blood supply from the external carotid artery and a complex innervation pattern involving both parasympathetic and sympathetic fibers.

Parotid gland disorders can include salivary gland stones (sialolithiasis), infections, inflammatory conditions, benign or malignant tumors, and autoimmune diseases such as Sjögren's syndrome.

Retroperitoneal fibrosis (RPF) is a rare and progressive condition characterized by the abnormal growth of fibrous tissue in the retroperitoneal space, which is the area behind the peritoneum (the lining that covers the abdominal cavity). This fibrous tissue can encase and compress vital structures such as the ureters, blood vessels, and nerves, leading to various symptoms.

RPF can be idiopathic (without a known cause) or secondary to other conditions like infections, malignancies, autoimmune diseases, or medications. The exact pathogenesis of RPF is not fully understood, but it's believed that an abnormal immune response and inflammation play significant roles in its development.

Symptoms of RPF may include:

1. Flank pain or back pain
2. Renal insufficiency or kidney failure due to ureteral compression
3. Hydronephrosis (dilatation of the renal pelvis and calyces)
4. Deep vein thrombosis (DVT) or pulmonary embolism (PE) due to vascular compression
5. Neurological symptoms due to nerve compression
6. Weight loss, fatigue, and fever (in some cases)

Diagnosis of RPF typically involves imaging studies such as computed tomography (CT) scans or magnetic resonance imaging (MRI), along with laboratory tests and sometimes biopsy for confirmation. Treatment options depend on the underlying cause but generally involve immunosuppressive medications, corticosteroids, and surgical intervention in severe cases.

Salivary gland neoplasms refer to abnormal growths or tumors that develop in the salivary glands. These glands are responsible for producing saliva, which helps in digestion, lubrication of food and maintaining oral health. Salivary gland neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign neoplasms are slow-growing and typically do not spread to other parts of the body. They may cause symptoms such as swelling, painless lumps, or difficulty swallowing if they grow large enough to put pressure on surrounding tissues.

Malignant neoplasms, on the other hand, can be aggressive and have the potential to invade nearby structures and metastasize (spread) to distant organs. Symptoms of malignant salivary gland neoplasms may include rapid growth, pain, numbness, or paralysis of facial nerves.

Salivary gland neoplasms can occur in any of the major salivary glands (parotid, submandibular, and sublingual glands) or in the minor salivary glands located throughout the mouth and throat. The exact cause of these neoplasms is not fully understood, but risk factors may include exposure to radiation, certain viral infections, and genetic predisposition.

Submandibular sialadenitis has been said to only account for 10% of all cases diagnosed as sialadenitis. Chronic sialadenitis ... sialadenitis may show no gross symptoms Chronic sialadenitis (also known as lymphoepithelial sialadenitis (LESA)) presents with ... whereas bacterial sialadenitis and sclerosing polycystic sialadenitis are defined as rare. Chronic sclerosing sialadenitis has ... Sialadenitis can be further classed as acute or chronic. Acute sialadenitis is an acute inflammation of a salivary gland which ...
Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ... Diagnosis and management of submandibular sialadenitis/sialadenosis. In evaluating the patient with sialadenitis, steps should ... encoded search term (Submandibular Sialadenitis/Sialadenosis) and Submandibular Sialadenitis/Sialadenosis What to Read Next on ... Submandibular Sialadenitis/Sialadenosis. Updated: Apr 18, 2022 * Author: Adi Yoskovitch, MD, MSc; Chief Editor: Arlen D Meyers ...
Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ... Acute sialadenitis. *. In cases of acute sialadenitis, adequate hydration should be ensured and electrolyte imbalances ... encoded search term (Submandibular Sialadenitis/Sialadenosis) and Submandibular Sialadenitis/Sialadenosis What to Read Next on ... Submandibular Sialadenitis/Sialadenosis Treatment & Management. Updated: Apr 18, 2022 * Author: Adi Yoskovitch, MD, MSc; Chief ...
Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ... Diagnosis and management of submandibular sialadenitis/sialadenosis. In evaluating the patient with sialadenitis, steps should ... encoded search term (Submandibular Sialadenitis/Sialadenosis) and Submandibular Sialadenitis/Sialadenosis What to Read Next on ... Submandibular Sialadenitis/Sialadenosis. Updated: Apr 18, 2022 * Author: Adi Yoskovitch, MD, MSc; Chief Editor: Arlen D Meyers ...
Salivary simulation with ascorbic acid enhances sonographic diagnosis of obstructive sialadenitis. Alessandro Bozzato, Victoria ...
Treatment indications included sialadenitis of unclear etiology (49%), sialadenitis with sialolithiasis (47%), and Sjögren ... BACKGROUND: Chronic sialadenitis is a relatively common disorder that is frequently referred to head and neck surgeons for ... Endoscopic-assisted management of chronic sialadenitis.. M Boyd Gillespie, Jared Intaphan, Shaun A Nguyen. Head & Neck 2011 ... METHODS: This study is a retrospective case series of patients undergoing salivary endoscopy for chronic sialadenitis. Patient ...
define Sialadenitis. Explain Sialadenitis. What is Sialadenitis? Sialadenitis FAQ. ... Sialadenitis. Medical Dictionary -> Sialadenitis. Search: Sialadenitis. INFLAMMATION of salivary tissue (SALIVARY GLANDS), ...
In addition to pain and glandular swelling, patients with sialolithiasis or sialadenitis can also present with fever, trismus, ... Sialolithiasis/Sialadenitis Vilija Vaitaitis Sanjey Gupta THE CLINICAL CHALLENGE Patients with salivary gland disease often ... Sialolithiasis is a leading cause of sialadenitis, or inflammation of the salivary gland(s). However, sialadenitis can be ... In sialadenitis, palpation of the gland often leads to expression of pus from the intraoral gland orifice.7 For the parotid ...
Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ... encoded search term (Submandibular Sialadenitis/Sialadenosis) and Submandibular Sialadenitis/Sialadenosis What to Read Next on ... Submandibular Sialadenitis/Sialadenosis Medication. Updated: Jun 25, 2015 * Author: Adi Yoskovitch, MD, MSc; Chief Editor: ... Gillespie MB, Koch M, Iro H, Zenk J. Endoscopic-Assisted Gland-Preserving Therapy for Chronic Sialadenitis: A German and US ...
Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ... encoded search term (Submandibular Sialadenitis/Sialadenosis) and Submandibular Sialadenitis/Sialadenosis What to Read Next on ... Submandibular Sialadenitis/Sialadenosis. Updated: Jun 25, 2015 * Author: Adi Yoskovitch, MD, MSc; Chief Editor: Arlen D Meyers ... Sialadenitis of the submandibular gland is a relatively commonly encountered yet infrequently discussed topic. Causes range ...
Salivary Gland Calculi/Sialadenitis answers are found in the 5-Minute Clinical Consult powered by Unbound Medicine. Available ... "Sialadenitis" is inflammation of the salivary gland classified as acute or chronic sialadenitis.*Acute can be caused by a ... Bacterial sialadenitis tends to be unifocal caused by Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes, ... Salivary Gland Calculi/Sialadenitis. In: Domino FJF, Baldor RAR, Golding JJ, et al, eds. 5-Minute Clinical Consult. Wolters ...
Call Us Today To Schedule Your Visit Or Visit Our Sialadenitis Page To Learn More! ... Sialadenitis. Sialadenitis is inflammation and enlargement of one or more of the salivary (spit) glands. The salivary glands ... What Causes Sialadenitis?. Sialadenitis can be caused by a viral infection (such as mumps), bacterial infection, or an ... What Are the Symptoms of Sialadenitis?. The symptoms of sialadenitis can include:. *Swelling in the cheek and neck region, ...
Sialadenitis - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional ... Etiology of Sialadenitis Sialadenitis usually occurs after hyposecretion or duct obstruction but may develop without an obvious ... Symptoms and Signs of Sialadenitis Fever, chills, and unilateral pain and swelling develop in patients with sialadenitis. The ... Initial treatment for sialadenitis is with antibiotics active against S. aureus (eg, dicloxacillin, 250 mg orally 4 times a day ...
Return to Article Details Kuttners tumour: chronic sclerosing sialadenitis- a mimicker of malignancy Download Download PDF ...
Sialadenitisd. 39. 1. Diarrhea. 25. 3. Abdominal paine. 23. 6. ...
Approach to sialadenitis. Moore J, Simpson MTW, Cohen N, Beyea JA, Phillips T. Moore J, et al. Can Fam Physician. 2023 Aug;69(8 ...
From: Parotid sialolithiasis and sialadenitis in a 3-year-old child: a case report and review of the literature ...
Sialadenitis. Pediatric Otolaryngology: Head and Neck Surgery, A Clinical Reference Guide, 2014 ...
Gastrointestinal: Sialadenitis, pancreatitis. There have been sporadic reports of pseudomembranous colitis with the use of ...
... nonspecific chronic sialadenitis, and sclerosing chronic sialadenitis. Such inflammation in the salivary glands may contribute ... focal lymphocytic sialadenitis; N/SCS: nonspecific/sclerosing chronic sialadenitis. *Significantly different from the other ... FLS: focal lymphocytic sialadenitis; GC: germinal center; RF: rheumatoid factor. * By either chi-square or Fishers exact test ... Importantly, 42 out of the 43 non-SS subjects had a certain type of sialadenitis in the labial salivary glands, including FLS, ...
Endoscopic-assisted management of chronic sialadenitis. Head Neck. 2011 Sep. 33(9):1346-51. [QxMD MEDLINE Link]. ...
Chronic inflammation (sialadenitis). *Formation of salivary stones. *Benign tumors or cysts. *Salivary cancers ...
Pancreatitis, jaundice (intrahepatic cholestatic), sialadenitis, vomiting, diarrhea, cramping, nausea, gastric irritation, ...
Sialadenitis *Mallory-Weiss Tear *Peptic Ulcer Disease *Pyloric Stenosis *Benign Prostatic Hyperplasia *Phenylketonuria * ...
J. T. Geyer, J. A. Ferry, N. L. Harris et al., "Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease ... sialadenitis, retroperitoneal fibrosis, and cholangitis. However, IgG4-RD can involve the vast majority of organs, including ...
The 10 Key Symptoms of Sialadenitis You Need to Know. Top 10 Causes of Swollen Parotid Glands (Parotitis) ...
Gastrointestinal: Sialadenitis, pancreatitis. There have been sporadic reports of pseudomembranous colitis with the use of ...
impotence, sialadenitis.. Thiazides alone have been shown to cause the following additional adverse reactions:. Central Nervous ...
"Pediatric sialadenitis". Otolaryngol Clin North Am. 47 (5): 763-78. doi:10.1016/j.otc.2014.06.009. PMID 25128215 ...

No FAQ available that match "sialadenitis"

No images available that match "sialadenitis"